Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resourc...Congress/Biomarkers-of-immune-therapy-in-CUP

BackgroundCarcinoma of unknown primary (CUP) accounts for approximately 3% of all malignancies. Identification of common cancer pathway alterations (hallmarks of cancer) in diverse cancer lineages...

Date: 11 Sep 2017
Presenter: Joanne Xiu
Resources: Abstract
Topics: Cancer in Adolescents, Carcinoma of Unknown Primary Site, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...tic-Targets-in-Carcinomas-of-Unknown-Primary

BackgroundCurrent cancer treatment paradigms are based on features of the primary tumour and extent of disease. Carcinoma of unknown primary (CUP) is a histologically confirmed metastatic cancer in...

Date: 10 Sep 2017
Presenter: Britt Clynick
Resources: Abstract
Topics: Basic Science, Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...n-primary-carcinoma-clinical-case-discussion

Date: 09 Sep 2017
Presenter: George Pentheroudakis
Resources: Presentation
Topic: Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...ion-Masterclass-in-Medical-Oncology-2017/CUP

Date: 18 Aug 2017
Presenter: N. Pavlidis, GR
Resources: Presentation
Topic: Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...nknown-primary-A-single-UK-centre-experience

In the United Kingdom between 2006-10, 57% of patients with Malignancy of Unknown Origin (MUO) and Carcinoma of Unknown Primary (CUP) presented via the emergency route with a dismal survival rate of 10% at 6 months.

Date: 28 Jun 2017
Presenter: Laura Jaques
Resources: Abstract
Topic: Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...ith-imaging-suggestive-of-metastatic-disease

In response to NICE guidelines (2010) “Diagnosis and Management of Metastatic Disease of Unknown Primary Origin (MUO)” the Royal Free Hospital (RFH), London established a multidisciplinary service...

Date: 28 Jun 2017
Presenter: Danny Ulahannan
Resources: Abstract
Topic: Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...ical-Oncology-2017/Cancer-of-Unknown-Primary

Date: 07 Jun 2017
Presenter: N. Pavlidis, GR
Resources: Presentation
Topic: Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...ble-subset-of-cancer-of-unknown-primary-site

BackgroundWilms tumor gene (WT-1) expression has been reported in most adenocarcinoma of ovary and peritoneum. Clinical characteristics of adenocarcinoma with Wilms tumor gene (WT-1) expression in...

Date: 18 Dec 2016
Presenter: Makoto Kodaira
Resources: Abstract
Topics: Carcinoma of Unknown Primary Site, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...n-Masterclass-2016/Cancer-of-Unknown-Primary

Date: 04 Jul 2016
Presenter: N. Pavlidis, GR
Resources: Presentation
Topic: Carcinoma of Unknown Primary Site

http://oncologypro.esmo.org/Meeting-Resourc...unknown-primary-a-multicenter-phase-II-study

Aim/BackgroundThe aim of the study was to assess the clinical activity and toxicity of oxaliplatin and leucovorin in combination with bolus and continuous infusion of 5-fluorouracil treated every 2...

Date: 19 Dec 2015
Presenter: Dong-Yeop Shin
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Carcinoma of Unknown Primary Site